Completed PHASE3 NCT00003855

Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Breast Cancer

Interventions axillary lymph node dissection whole breast irradiation

Updated 7 times since 2017 Last updated: Apr 28, 2020 Started: Apr 30, 1999 Primary completion: Aug 31, 2007 Completion: Feb 28, 2011

This PHASE3 trial investigates Breast Cancer and is currently completed. Alliance for Clinical Trials in Oncology leads this study, which shows 7 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
May 2020 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — May 2020 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abington, United States , Albany, United States , Allentown, United States , Ann Arbor, United States , Annapolis, United States , Asheville, United States , Aurora, United States , Austin, United States , Baltimore, United States , Baton Rouge, United States and 112 more locations